IL155341A0 - Control of the ratio of transcription activator to transcription inhibitor protein - Google Patents

Control of the ratio of transcription activator to transcription inhibitor protein

Info

Publication number
IL155341A0
IL155341A0 IL15534103A IL15534103A IL155341A0 IL 155341 A0 IL155341 A0 IL 155341A0 IL 15534103 A IL15534103 A IL 15534103A IL 15534103 A IL15534103 A IL 15534103A IL 155341 A0 IL155341 A0 IL 155341A0
Authority
IL
Israel
Prior art keywords
transcription
ratio
control
inhibitor protein
activator
Prior art date
Application number
IL15534103A
Other languages
English (en)
Original Assignee
Sumitomo Electric Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Electric Industries filed Critical Sumitomo Electric Industries
Publication of IL155341A0 publication Critical patent/IL155341A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL15534103A 2002-04-12 2003-04-10 Control of the ratio of transcription activator to transcription inhibitor protein IL155341A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002110197 2002-04-12

Publications (1)

Publication Number Publication Date
IL155341A0 true IL155341A0 (en) 2003-11-23

Family

ID=19193890

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15534103A IL155341A0 (en) 2002-04-12 2003-04-10 Control of the ratio of transcription activator to transcription inhibitor protein

Country Status (11)

Country Link
US (1) US20040002149A1 (de)
EP (1) EP1362867A3 (de)
KR (1) KR20030081187A (de)
CN (1) CN1451752A (de)
AU (1) AU2003203527A1 (de)
CA (1) CA2425021A1 (de)
IL (1) IL155341A0 (de)
NO (1) NO20031719L (de)
NZ (1) NZ525221A (de)
RU (1) RU2003110509A (de)
ZA (1) ZA200302924B (de)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769330A (en) * 1981-12-24 1988-09-06 Health Research, Incorporated Modified vaccinia virus and methods for making and using the same
US4797368A (en) * 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5139941A (en) * 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
EP0561034B1 (de) * 1991-08-26 1999-06-09 IMMUNO Aktiengesellschaft Direkt molekuläre Klonierung eines modifizierten Genoms eines Chordopocken-Virus
CA2098397C (en) * 1991-10-16 1999-07-06 Yohei Hirai Physiologically active substance designated as epimorphin, genes encoding the same, and antibodies thereto
US5837239A (en) * 1991-10-16 1998-11-17 Biomaterial Research Institute Co., Ltd. Physiologically active substance designated as epimorphin genes encoding the same and antibodies thereto
FR2688514A1 (fr) * 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
AU690905B2 (en) * 1993-03-04 1998-05-07 Baylor College Of Medicine The human C/EBP gene and vectors for its expression
FR2709309B1 (fr) * 1993-08-25 1995-11-10 Centre Nat Rech Scient Compositions cellulaires, préparation et utilisations thérapeutiques.
FR2712812B1 (fr) * 1993-11-23 1996-02-09 Centre Nat Rech Scient Composition pour la production de produits thérapeutiques in vivo.
US5871986A (en) * 1994-09-23 1999-02-16 The General Hospital Corporation Use of a baculovirus to express and exogenous gene in a mammalian cell
US20030166586A1 (en) * 2000-02-18 2003-09-04 Linda Sealy C/EBP beta isoforms and methods of use in cell regulation and anti-tumorigenesis
US6271030B1 (en) * 2000-06-14 2001-08-07 Isis Pharmaceuticals, Inc. Antisense inhibition of C/EBP beta expression

Also Published As

Publication number Publication date
NO20031719L (no) 2003-10-13
ZA200302924B (en) 2003-10-15
AU2003203527A1 (en) 2003-10-30
CN1451752A (zh) 2003-10-29
EP1362867A3 (de) 2004-06-02
NO20031719D0 (no) 2003-04-14
RU2003110509A (ru) 2005-01-20
KR20030081187A (ko) 2003-10-17
US20040002149A1 (en) 2004-01-01
EP1362867A2 (de) 2003-11-19
NZ525221A (en) 2005-06-24
CA2425021A1 (en) 2003-10-12

Similar Documents

Publication Publication Date Title
AU2003261434A1 (en) Iminothiazolidinones as inhibitors of hcv replication
IL164295A0 (en) Tri-substituted heteroaryls and methods of making and using the same
EP1549316A4 (de) HEMMER VON TFGbeta
AU2003215358A1 (en) Microbubbles of oxygen
IL163863A0 (en) Form of presentation for3-Ä(2-äÄ4-(hexyloxycarbonylamino-imino-methyl)-phenylaminoÜmethylü-1-methyl-1H-benzimidaz
PL377825A1 (pl) Diaminotriazole użyteczne jako inhibitory kinaz białkowych
AU2003294778A1 (en) Novel use of lycopene
ZA200701583B (en) Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1
AU2003243714A1 (en) Etoposide analogs and methods of use thereof
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
AU2003295336A1 (en) Use of etodoclac to treat hyperplasia
AU2003256764A1 (en) Point of use lighting controller
AU2003222065A1 (en) Chemiluminescent treatment of acne
PL373523A1 (en) Indol-2-ones as selective inhibitors of cyclooxygenase-2
AU2003220930A1 (en) Emthod of screening transporter inhibitor
PL371427A1 (en) New uses of substituted aminoalkanephosphonic acids
IL155341A0 (en) Control of the ratio of transcription activator to transcription inhibitor protein
AU2003263648A1 (en) Water saving apparatus with function of deodorization
AU2003249069A8 (en) Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1
AU2003228532A8 (en) Methods of use of the enzymes of mycothiol synthesis
AU2003225642A1 (en) Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs
AU2003248597A1 (en) The purification of 2-methoxy-5-trifluoromethoxybenzaldehyde
AU2003254867A1 (en) Novel uses of rfrp and ot7t022
AU2003206753A1 (en) Use of oxygen-enriched water
AU2003279244A8 (en) Biosynthesis of hif